Compare NNI & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNI | MANE |
|---|---|---|
| Founded | 1978 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.3B |
| IPO Year | 2003 | 2026 |
| Metric | NNI | MANE |
|---|---|---|
| Price | $125.82 | $131.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $163.50 |
| AVG Volume (30 Days) | 112.5K | ★ 795.6K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 134.86 | N/A |
| EPS | ★ 3.82 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $32.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $116.62 | $36.26 |
| 52 Week High | $144.38 | $136.72 |
| Indicator | NNI | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 66.97 |
| Support Level | $123.57 | $92.62 |
| Resistance Level | $128.94 | N/A |
| Average True Range (ATR) | 1.97 | 8.30 |
| MACD | 0.24 | 1.25 |
| Stochastic Oscillator | 59.73 | 82.26 |
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems, which focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Asset Generation and Management.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.